Literature DB >> 16040289

Flow cytometric immunophenotyping of adult T-cell leukemia/lymphoma using CD3 gating.

Taiji Yokote1, Toshikazu Akioka, Satoko Oka, Satoshi Hara, Kichinosuke Kobayashi, Hideto Nakajima, Takeshi Yamano, Toshiyuki Ikemoto, Akira Shimizu, Motomu Tsuji, Toshiaki Hanafusa.   

Abstract

Adult T-cell leukemia/lymphoma (ATLL) is a lymphoproliferative neoplasm of helper T lymphocytes caused by human T-cell leukemia virus type-1 (HTLV-1). The disease was first described in Kyushu, in southwestern Japan, and most frequently occurs in endemic areas, such as Japan, the Caribbean basin, West Africa, Brazil, and northern Iran. ATLL is essentially a disease of adults, characterized clinically by generalized lymphadenopathy, hepatosplenomegaly, skin lesions, and hypercalcemia. The prognosis of most patients is quite poor, with a median survival time of only 13 months, even if multiagent combination chemotherapy is given. In the present study, flow cytometric immunophenotyping with CD3 gating was performed on 30 samples from 26 patients who had been given a diagnosis of ATLL. The records of these patients also were reviewed retrospectively. In 14 of the 30 samples, an abnormal CD3(low) T-cell population was distinguishable from the normal T-cell populations by flow cytometric analysis. Herein we report a novel strategy for flow cytometric immunophenotyping of ATLL facilitated by CD3(low) gating.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16040289     DOI: 10.1309/KEN4-MXM5-Y9A1-GEMP

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  10 in total

1.  Flow cytometric immunophenotypic assessment of T-cell clonality by Vβ repertoire analysis: detection of T-cell clonality at diagnosis and monitoring of minimal residual disease following therapy.

Authors:  Prashant Tembhare; Constance M Yuan; Liqiang Xi; John C Morris; David Liewehr; David Venzon; John E Janik; Mark Raffeld; Maryalice Stetler-Stevenson
Journal:  Am J Clin Pathol       Date:  2011-06       Impact factor: 2.493

2.  CD3-CD4+ lymphoid variant of hypereosinophilic syndrome: nodal and extranodal histopathological and immunophenotypic features of a peripheral indolent clonal T-cell lymphoproliferative disorder.

Authors:  Guillaume Lefèvre; Marie-Christine Copin; Christophe Roumier; Hélène Aubert; Martine Avenel-Audran; Nathalie Grardel; Stéphanie Poulain; Delphine Staumont-Sallé; Julien Seneschal; Gilles Salles; Kamel Ghomari; Louis Terriou; Christian Leclech; Chafika Morati-Hafsaoui; Franck Morschhauser; Olivier Lambotte; Félix Ackerman; Jacques Trauet; Sandrine Geffroy; Florent Dumezy; Monique Capron; Catherine Roche-Lestienne; Alain Taieb; Pierre-Yves Hatron; Sylvain Dubucquoi; Eric Hachulla; Lionel Prin; Myriam Labalette; David Launay; Claude Preudhomme; Jean-Emmanuel Kahn
Journal:  Haematologica       Date:  2015-02-14       Impact factor: 9.941

3.  A unique bone marrow lymphoma patient presenting with an isolated mass: A case report.

Authors:  Yi-Wen Xu; Ming-Hui Duan
Journal:  Oncol Lett       Date:  2017-12-06       Impact factor: 2.967

4.  Visual inspection versus quantitative flow cytometry to detect aberrant CD2 expression in malignant T cells.

Authors:  Indu Arun; Jacqueline A Wulu; John E Janik; Gregory A Jasper; Constance M Yuan; David Venzon; Maryalice Stetler-Stevenson
Journal:  Cytometry B Clin Cytom       Date:  2010-05       Impact factor: 3.058

5.  Minimal residual disease detection by flow cytometry in adult T-cell leukemia/lymphoma.

Authors:  Haipeng Shao; Constance M Yuan; Liqiang Xi; Mark Raffeld; John C Morris; John E Janik; Maryalice Stetler-Stevenson
Journal:  Am J Clin Pathol       Date:  2010-04       Impact factor: 2.493

6.  Immune activation induces immortalization of HTLV-1 LTR-Tax transgenic CD4+ T cells.

Authors:  Alison Y Swaims; Francesca Khani; Yingyu Zhang; Arthur I Roberts; Satish Devadas; Yufang Shi; Arnold B Rabson
Journal:  Blood       Date:  2010-07-15       Impact factor: 22.113

Review 7.  Updates in lymph node and skin pathology of adult T-cell leukemia/lymphoma, biomarkers, and beyond.

Authors:  Brian D Adkins; Juan C Ramos; Meghan Bliss-Moreau; Alejandro A Gru
Journal:  Semin Diagn Pathol       Date:  2019-12-20       Impact factor: 3.464

8.  Dermatopathic reaction of lymph nodes in HTLV-1 carriers: a spectrum of reactive and neoplastic lesions.

Authors:  Shigeki Chinen; Takuya Miyagi; Yoshiya Murakami; Mitsuyoshi Takatori; Shugo Sakihama; Iwao Nakazato; Yoshiyuki Kariya; Sayaka Yamaguchi; Kenzo Takahashi; Kennosuke Karube
Journal:  Histopathology       Date:  2020-06-18       Impact factor: 5.087

9.  Progressive loss of CD3 expression after HTLV-I infection results from chromatin remodeling affecting all the CD3 genes and persists despite early viral genes silencing.

Authors:  Haidar Akl; Bassam Badran; Gratiela Dobirta; Germain Manfouo-Foutsop; Maria Moschitta; Makram Merimi; Arsène Burny; Philippe Martiat; Karen E Willard-Gallo
Journal:  Virol J       Date:  2007-09-06       Impact factor: 4.099

10.  A genetic IFN/STAT1/FAS axis determines CD4 T stem cell memory levels and apoptosis in healthy controls and Adult T-cell Leukemia patients.

Authors:  Ricardo Khouri; Gilvanéia Silva-Santos; Tim Dierckx; Soraya Maria Menezes; Daniele Decanine; Kristof Theys; Aline Clara Silva; Lourdes Farré; Achiléa Bittencourt; Massimo Mangino; Mario Roederer; Anne-Mieke Vandamme; Johan Van Weyenbergh
Journal:  Oncoimmunology       Date:  2018-02-13       Impact factor: 8.110

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.